# Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)

> **NCT00794625** · PHASE4 · UNKNOWN · sponsor: **Joseph Blader** · enrollment: 270 (estimated)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** Valproate
- **DRUG:** Risperidone
- **DRUG:** Placebo
- **DRUG:** Stimulant medication
- **BEHAVIORAL:** Behavioral family counseling

## Key facts

- **NCT ID:** NCT00794625
- **Lead sponsor:** Joseph Blader
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2012-11
- **Final completion:** 2013-04
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2012-07-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00794625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00794625, "Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00794625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*